Titel: Kirurgi - omistligt komplement till medicinsk behandling (serie: Tema kronisk tarminflammation) 2009 nr 45 sid 3003-9
Referenser:
1.Kock NG. Ileostomy without external appliances: a survey of 25 patients provided with intra-abdominal intestinal reservoir. Ann Surg 1971; 173(4):545-550.
2.Block M, Borjesson L, Lindholm E, Oresland T. Pouch design and long-term functional outcome after ileal pouch-anal anastomosis. Br J Surg 2009; 96(5):527-532.
3.Heuman R, Boeryd B, Bolin T, Sjödahl R. The influence of disease at the margin of resection on the outcome of Crohn's disease. Br J Surg 1983;70:519-21.
4.Henriksen M, Jahnsen J, Lygren I, Sauar J, Kjellevold O, Schulz T et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis 2006; 12(7):543-550.
5.Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992; 103(5):1444-1451.
6.Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990; 31(3):329-333.
7.Cottone M, Scimeca D, Mocciaro F, Civitavecchia G, Perricone G, Orlando A. Clinical course of ulcerative colitis. Dig Liver Dis 2008; 40 Suppl 2:S247-S252.
8.Hancock L, Windsor AC, Mortensen NJ. Inflammatory bowel disease: the view of the surgeon. Colorectal Dis 2006; 8 Suppl 1:10-14.
9.Hyde GM, Jewell DP, Kettlewell MG, Mortensen NJ. Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications. Dis Colon Rectum 2001; 44(10):1436-1440.
10.Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlen P, Granno C et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005; 128(7):1805-1811.
11.Travis SP, Stange EF, Lemann M, Öresland T, Bemelman WA, Chowers Y et al. European evidence-based Consensus on the management of ulcerative colitis: Current management. Journal of Crohn's and Colitis 2008; 2(1):24-62.
12.Hyman NH, Cataldo P, Osler T. Urgent subtotal colectomy for severe inflammatory bowel disease. Dis Colon Rectum 2005; 48(1):70-73.
13.Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 2003; 125(2):320-327.
14.Lake JP, Firoozmand E, Kang JC, Vassiliu P, Chan LS, Vukasin P et al. Effect of high-dose steroids on anastomotic complications after proctocolectomy with ileal pouch-anal anastomosis. J Gastrointest Surg 2004; 8(5):547-551.
15.Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 2007; 25(6):657-668.
16.Odze RD, Goldblum J, Noffsinger A, Alsaigh N, Rybicki LA, Fogt F. Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology. Mod Pathol 2002; 15(4):379-386.
17.Biancone L, Michetti P, Travis SP, Escher JC, Moser G, Forbes A et al. European evidence-based Consensus on the management of ulcerative colitis: Special situations. Journal of Crohn's and Colitis 2008; 2(1):63-92.
18.Befrits R, Ljung T, Jaramillo E, Rubio C. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis Colon Rectum 2002; 45(5):615-620.
19.Lim CH, Axon AT. Low-grade dysplasia: nonsurgical treatment. Inflamm Bowel Dis 2003; 9(4):270-272.
20.Wong KS, Remzi FH, Gorgun E, Arrigain S, Church JM, Preen M et al. Loop ileostomy closure after restorative proctocolectomy: outcome in 1,504 patients. Dis Colon Rectum 2005; 48(2):243-250.
21.Williamson ME, Lewis WG, Sagar PM, Holdsworth PJ, Johnston D. One-stage restorative proctocolectomy without temporary ileostomy for ulcerative colitis: a note of caution. Dis Colon Rectum 1997; 40(9):1019-1022.
22.Tjandra JJ, Fazio VW, Milsom JW, Lavery IC, Oakley JR, Fabre JM. Omission of temporary diversion in restorative proctocolectomy--is it safe? Dis Colon Rectum 1993; 36(11):1007-1014.
23.Matthiessen P, Hallbook O, Rutegard J, Simert G, Sjodahl R. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg 2007; 246(2):207-214.
24.Tjandra JJ, Fazio VW, Church JM, Oakley JR, Milsom JW, Lavery IC. Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis. Am J Surg 1993; 165:322-325.
25.Berndtsson I, Lindholm E, Oresland T, Borjesson L. Long-term outcome after ileal pouch-anal anastomosis: function and health-related quality of life. Dis Colon Rectum 2007; 50(10):1545-1552.
26.Ståhlberg D, Gullberg K, Liljeqvist L, Hellers G, Löfberg R. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996; 39(9):1012-1018.
27.Leowardi C, Hinz U, Tariverdian M, Kienle P, Herfarth C, Ulrich A et al. Long-term outcome 10 years or more after restorative proctocolectomy and ileal pouch-anal anastomosis in patients with ulcerative colitis. Langenbecks Arch Surg 2009.
28.Ferrante M, Declerck S, De Hertogh G, Van Assche G, Geboes K, Rutgeerts P et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis 2008; 14(1):20-28.
29.Cornish JA, Tan E, Teare J, Teoh TG, Rai R, Darzi AW et al. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum 2007; 50(8):1128-1138.
30.Ording OK, Juul S, Berndtsson I, Oresland T, Laurberg S. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology 2002; 122(1):15-19.
31.Börjesson L, Willen R, Haboubi N et al. The risk of dysplasia and cancer in the ileal pouch mucosa after restorative proctocolectomy for ulcerative proctocolitis is low: a long-term term follow-up study. Colorectal Dis 2004;6(6):494-8.
32.Aylett SO. Diffuse ulcerative colitis and its treatment by ileo-rectal anastomosis. Ann R Coll Surg Engl 1960; 27:260-284.
33.Leijonmarck CE, Löfberg R, Öst A, Hellers G. Long-term results of ileorectal anastomosis in ulcerative colitis in Stockholm County. Dis Colon Rectum 1990; 33(3):195-200.
34.Elton C, Makin G, Hitos K, Cohen CR. Mortality, morbidity and functional outcome after ileorectal anastomosis. Br J Surg 2003; 90(1):59-65.
35.Olsen KO, Juul S, Bulow S, Jarvinen HJ, Bakka A, Bjork J et al. Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg 2003; 90(2):227-231.
36.Poppen B, Svenberg T, Bark T. Perineal excision of the rectum. Br J Surg 1996;83(3):366-7.
37.Nessar G, Fazio VW, Tekkis P, Connor J, Wu J, Bast J et al.: Long-term outcome and quality of life after continent ileostomy. Dis Colon Rectum 2006; 49(3):336-344.
38.Sjödahl R, Nyström PO, Olaison G: Surgical treatment of dorsocaudal dislocation of the vagina after excision of the rectum. The Kylberg operation. Dis Colon Rectum 1990; 33(9):762-764.
39.Smedh K, Olaison G, Nystrom PO, Sjodahl R. Intraoperative enteroscopy in Crohn's disease. Br J Surg 1993; 80(7):897-900.
40.Nordgren SR, Fasth SB, Öresland TO, Hulten LA. Long-term follow-up in Crohn's disease. Mortality, morbidity, and functional status. Scand J Gastroenterol 1994;29:1122-8.
41.Kim NK, Senagore AJ, Luchtefeld MA, et al. Long-term outcome after ileocecal resection for Crohn's disease. Am Surg 1997;63:627-33.
42.Tillinger W, Mittermaier C, Lochs H, Moser G. Health-related quality of life in patients with Crohn's disease: influence of surgical operation--a prospective trial. Dig Dis Sci 1999;44:932-8.
43.Vermeire S, Van Assche G, Rutgeerts P. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol 2005; 2(12):580-586.
44.Solem CA, Loftus EV, Jr., Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11(8):707-712.
45.Munoz-Juarez M, Yamamoto T, Wolff BG, Keighley MR. Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn's disease. Dis Colon Rectum 2001;44:20-5; discussion 25-6.
46.Scarpa M, Angriman I, Barollo M, et al. Role of stapled and hand-sewn anastomoses in recurrence of Crohn's disease. Hepatogastroenterology 2004;51:1053-7.
47.Yamamoto T, Bain IM, Mylonakis E, Allan RN, Keighley MR. Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn disease. Scand J Gastroenterol 1999;34:708-13.
48.Tersigni R, Alessandroni L, Barreca M, Piovanello P, Prantera C. Does stapled functional end-to-end anastomosis affect recurrence of Crohn's disease after ileocolonic resection? Hepatogastroenterology 2003;50:1422-5.
49.Scott NA, Sue-Ling HM, Hughes LE. Anastomotic configuration does not affect recurrence of Crohn's disease after ileocolonic resection. Int J Colorectal Dis 1995;10:67-9.
50.Ikeuchi H, Kusunoki M, Yamamura T. Long-term results of stapled and hand-sewn anastomoses in patients with Crohn's disease. Dig Surg 2000;17:493-6.
51.Simillis C, Purkayastha S, Yamamoto T, Strong SA, Darzi AW, Tekkis PP. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn's disease. Dis Colon Rectum 2007; 50(10):1674-1687.
52.Hassan C, Zullo A, De F, V, Ierardi E, Giustini M, Pitidis A et al. Systematic review: Endoscopic dilatation in Crohn's disease. Aliment Pharmacol Ther 2007; 26(11-12):1457-1464.
53.Breysem Y, Janssens JF, Coremans G, et al. Endoscopic balloon dilation of colonic and ileo-colonic Crohn's strictures: long-term results. Gastrointest Endosc 1992;38:142-7.
54.Thomas-Gibson S, Brooker JC, Hayward CM, et al. Colonoscopic balloon dilation of Crohn's strictures: a review of long-term outcomes. Eur J Gastroenterol Hepatol 2003;15:485-8.
55.Broering DC, Eisenberger CF, Koch A, et al. Strictureplasty for large bowel stenosis in Crohn's disease: quality of life after surgical therapy. Int J Colorectal Dis 2001;16:81-7.
56.Reese GE, Purkayastha S, Tilney HS, von Roon A, Yamamoto T, Tekkis PP. Strictureplasty vs resection in small bowel Crohn's disease: an evaluation of short-term outcomes and recurrence. Colorectal Dis 2007; 9(8):686-694.
57.Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn's disease: a systematic review and meta-analysis. Dis Colon Rectum 2007; 50(11):1968-1986.
58.Fearnhead NS, Chowdhury R, Box B, George BD, Jewell DP, Mortensen NJ. Long-term follow-up of strictureplasty for Crohn's disease. Br J Surg 2006; 93(4):475-482.
59.Fichera A, Lovadina S, Rubin M, Cimino F, Hurst RD, Michelassi F. Patterns and operative treatment of recurrent Crohn's disease: a prospective longitudinal study. Surgery 2006; 140(4):649-654.
60.Sampietro GM, Sartani A, Danelli P, et al. [Strictureplasty in the surgical treatment of complicated Crohn's disease]. Ann Ital Chir 2003;74:659-63.
61.Tonelli F, Fedi M, Paroli GM, Fazi M. Indications and results of side-to-side isoperistaltic strictureplasty in Crohn's disease. Dis Colon Rectum 2004;47:494-501.
62.Shatari T, Clark MA, Yamamoto T, et al. Long strictureplasty is as safe and effective as short strictureplasty in small-bowel Crohn's disease. Colorectal Dis 2004;6:438-41.
63.Poggioli G, Laureti S, Pierangeli F, Ugolini F. A new model of strictureplasty for multiple and long stenoses in Crohn's ileitis: side-to-side diseased to disease-free anastomosis. Dis Colon Rectum 2003;46:127-30.
64.Tichansky D, Cagir B, Yoo E, Marcus SM, Fry RD. Strictureplasty for Crohn's disease: meta-analysis. Dis Colon Rectum 2000;43:911-9.
65.Michelassi F, Upadhyay GA. Side-to-side isoperistaltic strictureplasty in the treatment of extensive Crohn's disease. J Surg Res 2004;117:71-8.
66.Menon AM, Mirza AH, Moolla S, Morton DG. Adenocarcinoma of the small bowel arising from a previous strictureplasty for Crohn's disease: report of a case. Dis Colon Rectum 2007; 50(2):257-259.
67.Gervais DA, Hahn PF, O'Neill MJ, Mueller PR. Percutaneous abscess drainage in Crohn disease: technical success and short- and long-term outcomes during 14 years. Radiology 2002;222:645-51.
68.Garcia JC, Persky SE, Bonis PA, Topazian M. Abscesses in Crohn's disease: outcome of medical versus surgical treatment. J Clin Gastroenterol 2001;32:409-12.
69.Yamaguchi A, Matsui T, Sakurai T, et al. The clinical characteristics and outcome of intraabdominal abscess in Crohn's disease. J Gastroenterol 2004;39:441-8.
70.Aratari A, Papi C, Leandro G, Viscido A, Capurso L, Caprilli R. Early versus late surgery for ileo-caecal Crohn's disease. Aliment Pharmacol Ther 2007; 26(10):1303-1312.
71.Weston LA, Roberts PL, Schoetz DJ, Jr., et al. Ileocolic resection for acute presentation of Crohn's disease of the ileum. Dis Colon Rectum 1996;39:841-6.
72.Andersson P, Olaison G, Hallbook O, Sjodahl R. Segmental resection or subtotal colectomy in Crohn's colitis? Dis Colon Rectum 2002;45:47-53.
73.Bernell O, Lapidus A, Hellers G. Recurrence after colectomy in Crohn's colitis. Dis Colon Rectum 2001;44:647-54; discussion 654.
74.Allan A, Andrews H, Hilton CJ, et al. Segmental colonic resection is an appropriate operation for short skip lesions due to Crohn's disease in the colon. World J Surg 1989;13:611-4; discussion 615-6.
75.Yamamoto T, Keighley MR. Proctocolectomy is associated with a higher complication rate but carries a lower recurrence rate than total colectomy and ileorectal anastomosis in Crohn colitis. Scand J Gastroenterol 1999;34:1212-5.
76.Tonelli F, Paroli GM. [Colorectal Crohn's disease: indications to surgical treatment]. Ann Ital Chir 2003;74:665-72.
77.Longo WE, Ballantyne GH, Cahow CE. Treatment of Crohn's colitis. Segmental or total colectomy? Arch Surg 1988;123:588-90.
78.Broering DC, Eisenberger CF, Koch A, et al. Strictureplasty for large bowel stenosis in Crohn's disease: quality of life after surgical therapy. Int J Colorectal Dis 2001;16:81-7.
79.Reese GE, Lovegrove RE, Tilney HS, Yamamoto T, Heriot AG, Fazio VW et al. The effect of Crohn's disease on outcomes after restorative proctocolectomy. Dis Colon Rectum 2007; 50(2):239-250.
80.Prudhomme M, Dehni N, Dozois RR, Tiret E, Parc R. Causes and outcomes of pouch excision after restorative proctocolectomy. Br J Surg 2006; 93(1):82-86.
81.Brown CJ, Maclean AR, Cohen Z, Macrae HM, O'Connor BI, McLeod RS. Crohn's disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure. Dis Colon Rectum 2005; 48(8):1542-1549.
82.Rutgeerts P. Treatment of perianal fiatulizing Crohn's disease. Aliment Pharmacol her 2004;20 (suppl 4):106-10.
83.Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995;123:132-42.
84.Kasparek MS, et al. Long-term quality of life in patients with Crohn's disease and perianal fisutlas: influence of fecal diversion. Dis Colon Rectum 2007;50:2067-74.
85.Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar MM, Freitas JL, Mouzas IA, Baert F, Mitchell R, Hawkey CJ. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut. 2006;55 Suppl 1:i36-58.
86.Marcello PW, Milsom JW, Wong SK, Hammerhofer KA, Goormastic M, Church JM et al. Laparoscopic restorative proctocolectomy: case-matched comparative study with open restorative proctocolectomy. Dis Colon Rectum 2000; 43(5):604-608.
87.Dunker MS, Bemelman WA, Slors JF, van Duijvendijk P, Gouma DJ. Functional outcome, quality of life, body image, and cosmesis in patients after laparoscopic-assisted and conventional restorative proctocolectomy: a comparative study. Dis Colon Rectum 2001; 44(12):1800-1807.
88.Tan JJ, Tjandra JJ. Laparoscopic surgery for ulcerative colitis - a meta-analysis. Colorectal Dis 2006; 8(8):626-636.
89.Maartense S, Dunker MS, Slors JF, Gouma DJ, Bemelman WA. Restorative proctectomy after emergency laparoscopic colectomy for ulcerative colitis: a case-matched study. Colorectal Dis 2004; 6(4):254-257.
90.Ahmed AU, Keus F, Heikens JT, Bemelman WA, Berdah SV, Gooszen HG et al. Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis. Cochrane Database Syst Rev 2009;(1):CD006267.
91.Tan JJ, Tjandra JJ. Laparoscopic surgery for Crohn's disease: a meta-analysis. Dis Colon Rectum 2007; 50(5):576-585.
92.Tilney HS, Constantinides VA, Heriot AG, Nicolaou M, Athanasiou T, Ziprin P et al. Comparison of laparoscopic and open ileocecal resection for Crohn's disease: a metaanalysis. Surg Endosc 2006; 20(7):1036-1044.
93.Lesperance K, Martin MJ, Lehmann R, Brounts L, Steele SR. National Trends and Outcomes for the Surgical Therapy of Ileocolonic Crohn's Disease: A Population-Based Analysis of Laparoscopic vs. Open Approaches. J Gastrointest Surg 2009.
94.Maartense S, Dunker MS, Slors JF, Cuesta MA, Pierik EG, Gouma DJ et al. Laparoscopic-assisted versus open ileocolic resection for Crohn's disease: a randomized trial. Ann Surg 2006; 243(2):143-149.
95.Milsom JW, Hammerhofer KA, Bohm B, et al. Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease. Dis Colon Rectum 2001;44:1-8; discussion 8-9.
96.Stocchi L, Milsom JW, Fazio VW. Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn's disease: follow-up of a prospective randomized trial. Surgery 2008; 144(4):622-627.
97.Lawes DA, Motson RW. Avoidance of laparotomy for recurrent disease is a long-term benefit of laparoscopic resection for Crohn's disease. Br J Surg 2006; 93(5):607-608.
98.Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 2003; 125(2):320-327.
99.Yamamoto T, Allan RN, Keighley MR. Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum 2000;43:1141-5.
100.Heuschen UA, Hinz U, Allemeyer EH, et al. Risk factors for ileoanal J pouch-related septic complications in ulcerative colitis and familial adenomatous polyposis. Ann Surg 2002;235:207-16.
101.Mahadevan U, Loftus EV, Jr., Tremaine WJ, et al. Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications. Inflamm Bowel Dis 2002;8:311-6.
102.Tay GS, Binion DG, Eastwood D, Otterson MF. Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery 2003;134:565-72; discussion 572-3.
103.Travis SP, Stange EF, Lemann M, Öresland T, Bemelman WA, Chowers Y et al. European evidence-based Consensus on the management of ulcerative colitis: Current management. Journal of Crohn's and Colitis 2008; 2(1):24-62.
104.Myrelid P, Andersson P, Sjödahl R, Olaison G. Immunosuppression for Crohn´s disease is associated with increased frequency of anastomotic complications. Dis Colon Rectum 2009; in press
105.Ferrante M, D'Hoore A, Vermeire S, Declerck S, Noman M, Van Assche G et al.: Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis 2009, in press.
106.Schluender SJ, Ippoliti A, Dubinsky M, Vasiliauskas EA, Papadakis KA, Mei L et al.: Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis? Dis Colon Rectum 2007; 50(11):1747-1753.
107.Selvasekar CR, Cima RR, Larson DW, Dozois EJ, Harrington JR, Harmsen WS et al.: Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007; 204(5):956-962.
108.Mor IJ, Vogel JD, da Luz MA, Shen B, Hammel J, Remzi FH: Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 2008; 51(8):1202-1207.
109.Dinnewitzer AJ, Wexner SD, Baig MK, Oberwalder M, Pishori T, Weiss EG et al.: Timing of restorative proctectomy following subtotal colectomy in patients with inflammatory bowel disease. Colorectal Dis 2006; 8(4):278-282.
110.Colombel JF, Loftus EV, Jr., Tremaine WJ, et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004;99:878-83.
111.Appau KA, Fazio VW, Shen B, Church JM, Lashner B, Remzi F et al. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. J Gastrointest Surg 2008; 12(10):1738-1744.
![]() 3003 |
![]() 3004 |
![]() 3005 |
![]() 3006 |
![]() 3007 |
![]() 3008 |
![]() 3009 |